Medicine & Life Sciences
SC 560
91%
Hepatopulmonary Syndrome
85%
Cyclooxygenase Inhibitors
65%
Prostaglandin-Endoperoxide Synthases
58%
Hypoxia
43%
Indomethacin
32%
Cyclooxygenase 1
28%
Celecoxib
27%
Pneumonia
26%
Arterial Pressure
17%
Hemodynamics
16%
Portal Pressure
14%
Inflammation
12%
Cyclooxygenase 2 Inhibitors
12%
Common Bile Duct
12%
Liver
11%
Mortality
11%
Vasodilation
10%
Liver Cirrhosis
10%
Biochemistry
9%
Ligation
9%
Vascular Endothelial Growth Factor A
9%
Liver Diseases
9%
Fibrosis
8%
Chronic Disease
8%
Blood Vessels
6%
Kidney
5%
Proteins
4%
Agriculture & Biology
prostaglandin synthase
61%
angiogenesis
44%
hypoxia
42%
inflammation
41%
cyclooxygenase inhibitors
37%
indomethacin
29%
rats
28%
liver cirrhosis
25%
lungs
21%
hemodynamics
20%
cyclooxygenase 2 inhibitors
15%
liver diseases
12%
bile ducts
11%
vasodilation
10%
blood pressure
9%
biochemistry
8%
prostaglandins
8%
blood vessels
7%
protein synthesis
6%
kidneys
6%
liver
5%
methodology
2%
Chemical Compounds
Intrapulmonary
100%
EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthase) Inhibitor
62%
Cyclooxygenase 1 Inhibitor
51%
Hemodynamic
40%
Celecoxib
39%
Cyclooxygenase 2 Inhibitor
20%
Blood Pressure
17%
Prostaglandin
15%
Biochemistry
12%
Pressure
7%
Protein
5%